Items where Author is "Atyabi, F."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 3.

Article

Jafari, R. and Zolbanin, N. M. and Majidi, J. and Atyabi, F. and Yousefi, M. and Jadidi-Niaragh, F. and Aghebati-Maleki, L. and Shanehbandi, D. and Zangbar, M. S. S. and Rafatpanah, H. (2019) Anti-mucin1 aptamer-conjugated chitosan nanoparticles for targeted co-delivery of docetaxel and IGF-1R siRNA to SKBR3 metastatic breast cancer cells. Iranian Biomedical Journal, 23 (1). pp. 21-33.

Alibolandi, M. and Sadeghi, F. and Abnous, K. and Atyabi, F. and Ramezani, M. and Hadizadeh, F. (2019) Corrigendum to “The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model.” Eur. J. Pharm. Biopharm. 94 (2015) 521–531(S0939-6411(19)30181-X)(10.1016/j.ejpb.2019.02.005). European Journal of Pharmaceutics and Biopharmaceutics, 142. p. 540.

Zolbanin, N. M. and Jafari, R. and Majidi, J. and Atyabi, F. and Yousefi, M. and Jadidi-Niaragh, F. and Aghebati-Maleki, L. and Shanehbandi, D. and Zangbar, M. S. and Nayebi, A. M. (2018) Targeted co-delivery of docetaxel and cMET siRNA for treatment of mucin1 overexpressing breast cancer cells. Advanced Pharmaceutical Bulletin, 8 (3). pp. 383-393.

This list was generated on Wed Jul 8 19:09:35 2020 EDT.